🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals administering products of unknown origin.

Some professionals said the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Material Elimination

According to TikTok, the service has taken down violative material and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Research also discovered groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, glowing reviews and detailed guides for preparing or administering at home.

Within minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, health issues or past usage.

Item Details and Pricing

Within these communities, posts show black plastic packages with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When questioned how long a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.